TMDX

TransMedics Group Inc (TMDX)

US
$ 123.341.67%

Price Chart

Key Statistics

Market Cap
$ 3.72B
P/E Ratio
77.44
Revenue (TTM)
$ 488.23M
Volume
737.72K
52W High
$ 177.37
52W Low
$ 55.00
Dividend Yield
0.00%
Beta
2.05

Technicals

50-Day MA
125.9686
200-Day MA
92.4564
52 Week High
177.37
52 Week Low
55

About TMDX

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Employees
728
Headquarters
Andover, MA
CEO
Dr. Waleed H. Hassanein M.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg